Our Doxofylline 800 mg SR (Sustained Release) and Montelukast 10 mg Tablets are a combination medication designed for the management of asthma and chronic obstructive pulmonary disease (COPD). This advanced formulation provides a dual-action approach to help patients breathe easier, combining the strengths of two potent ingredients to offer more comprehensive respiratory support.
This medication is primarily used in the treatment of:
It helps to relieve wheezing, shortness of breath, and other breathing difficulties associated with these conditions.
While most patients do not experience severe side effects, some may encounter:
If you experience these or any other side effects, consult your healthcare provider immediately.
Take this medication as prescribed by your healthcare provider, usually once daily. Swallow the tablet whole, without crushing or chewing, to maintain the integrity of its sustained-release feature. It can be taken with or without food.
Doxofylline is a xanthine derivative that relaxes the muscles in the lungs, widening the airways and making it easier to breathe. Montelukast is a leukotriene receptor antagonist that reduces inflammation in the lungs and nasal passages, further easing breathing.
Store the tablets in a cool, dry place away from direct sunlight and moisture. Keep the medication out of reach of children and pets.
Doxofylline 800 mg SR and Montelukast 10 mg Tablets by JoinHub Pharma, exemplifies pharmaceutical excellence, meticulously crafted to exceed industry standards. Renowned for our unwavering commitment to quality, as WHO-GMP and EU-GMP Manufacturers, suppliers, and exporters, we assure unparalleled efficacy and reliability.
For further information on Doxofylline 800 mg SR and Montelukast 10 mg Tablets, please contact us via email at [email protected] or call us at +91-9724725604.